Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChangTai Keli with chemotherapy in colon cancer
NCT02510118Phase 3Unknown
- Sponsor
- Nanjing Ningqi Pharmaceutical Technology
- Start
- Jun 2015
- Primary completion
- Jun 2016
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of ChangTai Keli in colon cancer, sponsored by Nanjing Ningqi Pharmaceutical Technology. Status: unknown.
02
Drugs
ChangTai Keli
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02510118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02510118.